EMA Application withdrawn: Diractin (ketoprofen) — IDEA AG

View source ↗

Summary

EMA confirms withdrawal of the Diractin (ketoprofen) application by IDEA AG for osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Diractin (Ketoprofen)

Snippet

Status: Application withdrawn. Therapeutic area: Osteoarthritis. MAH: IDEA AG. Decision date: 31/12/2009